Market Closed -
Hong Kong S.E.
04:09:00 2024-05-03 am EDT
|
5-day change
|
1st Jan Change
|
0.95
HKD
|
+1.06%
|
|
0.00%
|
+15.85%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
1,855
|
1,405
|
1,977
|
2,840
|
1,279
|
871.1
|
Enterprise Value (EV)
1 |
1,491
|
1,874
|
2,434
|
1,168
|
-1,131
|
-512.2
|
P/E ratio
|
15.3
x
|
0.84
x
|
24.1
x
|
4.49
x
|
1.73
x
|
8.22
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
6.47
x
|
4.52
x
|
5.46
x
|
11.5
x
|
4.71
x
|
1.62
x
|
EV / Revenue
|
5.2
x
|
6.03
x
|
6.72
x
|
4.72
x
|
-4.17
x
|
-0.95
x
|
EV / EBITDA
|
23.1
x
|
22.9
x
|
35.1
x
|
91.9
x
|
-14
x
|
-2.92
x
|
EV / FCF
|
-1.4
x
|
1.51
x
|
71.1
x
|
-0.55
x
|
-0.51
x
|
2.17
x
|
FCF Yield
|
-71.3%
|
66.2%
|
1.41%
|
-181%
|
-197%
|
46.2%
|
Price to Book
|
0.67
x
|
0.31
x
|
0.43
x
|
0.56
x
|
0.34
x
|
0.22
x
|
Nbr of stocks (in thousands)
|
1,568,632
|
1,569,246
|
1,569,246
|
1,569,246
|
1,569,246
|
1,565,632
|
Reference price
2 |
1.183
|
0.8956
|
1.260
|
1.810
|
0.8148
|
0.5564
|
Announcement Date
|
4/27/18
|
4/24/19
|
4/28/20
|
4/23/21
|
4/21/22
|
4/26/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
286.9
|
310.8
|
362.2
|
247.4
|
271.4
|
536.8
|
EBITDA
1 |
64.42
|
81.84
|
69.27
|
12.71
|
80.86
|
175.5
|
EBIT
1 |
44.7
|
61.81
|
40.86
|
-14.92
|
49.95
|
98.17
|
Operating Margin
|
15.58%
|
19.89%
|
11.28%
|
-6.03%
|
18.4%
|
18.29%
|
Earnings before Tax (EBT)
1 |
45.08
|
126.6
|
85.81
|
626.6
|
737.5
|
157.7
|
Net income
1 |
122.1
|
1,666
|
81.98
|
631.8
|
739.1
|
106
|
Net margin
|
42.55%
|
535.89%
|
22.64%
|
255.43%
|
272.34%
|
19.75%
|
EPS
2 |
0.0774
|
1.062
|
0.0522
|
0.4026
|
0.4710
|
0.0677
|
Free Cash Flow
1 |
-1,063
|
1,240
|
34.23
|
-2,117
|
2,230
|
-236.5
|
FCF margin
|
-370.34%
|
398.93%
|
9.45%
|
-855.79%
|
821.81%
|
-44.06%
|
FCF Conversion (EBITDA)
|
-
|
1,514.98%
|
49.42%
|
-
|
2,758.32%
|
-
|
FCF Conversion (Net income)
|
-
|
74.44%
|
41.76%
|
-
|
301.76%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/27/18
|
4/24/19
|
4/28/20
|
4/23/21
|
4/21/22
|
4/26/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
469
|
457
|
-
|
-
|
-
|
Net Cash position
1 |
365
|
-
|
-
|
1,671
|
2,409
|
1,383
|
Leverage (Debt/EBITDA)
|
-
|
5.727
x
|
6.598
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
-1,063
|
1,240
|
34.2
|
-2,117
|
2,230
|
-237
|
ROE (net income / shareholders' equity)
|
1.28%
|
3.11%
|
1.8%
|
13%
|
16.6%
|
3.06%
|
ROA (Net income/ Total Assets)
|
0.99%
|
0.92%
|
0.48%
|
-0.18%
|
0.68%
|
1.38%
|
Assets
1 |
12,358
|
180,320
|
16,931
|
-360,419
|
108,902
|
7,695
|
Book Value Per Share
2 |
1.760
|
2.860
|
2.940
|
3.260
|
2.420
|
2.520
|
Cash Flow per Share
2 |
0.2300
|
0.0600
|
0.0800
|
1.080
|
1.460
|
0.8800
|
Capex
1 |
260
|
124
|
47.4
|
7.88
|
11.3
|
52.5
|
Capex / Sales
|
90.65%
|
39.8%
|
13.08%
|
3.18%
|
4.17%
|
9.77%
|
Announcement Date
|
4/27/18
|
4/24/19
|
4/28/20
|
4/23/21
|
4/21/22
|
4/26/23
|
|
1st Jan change
|
Capi.
|
---|
| +15.85% | 190M | | -30.75% | 3.08B | | -15.97% | 2.53B | | +18.11% | 2.47B | | +7.78% | 2.1B | | -9.47% | 1.91B | | -0.56% | 1.51B | | +2.24% | 1.34B | | +24.32% | 1.24B | | +3.86% | 1.13B |
Medical Supplies
|